Biotechnology News

July 23, 2012

GENEVA & WASHINGTON & MONTREAL--(BUSINESS WIRE)--Launch of 2 Fields 2 Goal: Protecting the Integrity of Science and Sports campaign to stop doping in sports.

July 23, 2012

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/...

July 23, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Nation’s largest bundled payment collaborative helping health systems succeed in public and private market arrangements

July 23, 2012

IRVINE, Calif.--(BUSINESS WIRE)--HALO Healthcare is developing biomarkers for early detection of breast cancer. The kit will use nipple aspirate fluid collected with the HALO Breast Test to detect breast cancer in women.

July 23, 2012

NEWTON, Mass.--(BUSINESS WIRE)--Galectin Therapeutics has received a notice of issuance from the USPTO for key methods of derivation and use for the Company’s carbohydrate-based galectin inhibitor compound in liver fibrosis.

July 23, 2012

NORTH ANDOVER, Mass.--(BUSINESS WIRE)--Aurora Imaging Technology Announces Exclusive China Distribution Agreement With SUMEC Group Corporation

July 23, 2012

ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, announced today that it plans to release financial results from the second quarter on Tuesday, July 31, 2012...

July 23, 2012

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE MKT: MDGN and MDGN.WS and AIM: MEDG and MEDU), the developer of BiopumpTM, a novel technology for the sustained production and delivery of therapeutic proteins in patients...

July 23, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB: INSV) announced today that it will report financial results for the second quarter ended June 30, 2012 on Tuesday, July 31, 2012. Company management will host a conference call...

July 23, 2012

NEW YORK--(BUSINESS WIRE)--Hyperion Therapeutics' anti-takeover measures could be risk factor for public investors in this week's biotech IPO.

July 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Gen9 Sponsors Contest to Recognize Innovation in Synthetic Biology

July 23, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Head-to-Head Study Comparing Navidea’s AZD4694 to the Gold Standard for Imaging Beta Amyloid Protein Deposits Presented at Alzheimer's Association International Conference

July 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the BMO Capital Markets Biotech Corporate Access Day on July 31, 2012, in Boston. In addition, Infinity will be participating in the...

July 23, 2012

SAN DIEGO--(BUSINESS WIRE)--Cancer Index by Mentor Capital (MNTR) is up 29% for 2012 YTD vs 12% for NASDAQ YTD. Immunocellular Therapeutics (IMUC) leads the Index. MNTR is up 372% in 2012 YTD.

July 23, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced the issuance of patents 8,207,233 and 8,207,234 by the U.S. Patent and Trademark...

July 23, 2012

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. has retained Australia Biologics Pty. Ltd. as a regulatory consultant to develop a roadmap for human clinical studies of its FluCide(tm) anti-influenza drug candidate in Australia

July 23, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) today announced that the company has sought leave to file counterclaims against Intelligent Bio-Systems, Inc. (IBS) and Qiagen NV, which recently acquired IBS, in response to the patent...

July 23, 2012

JERUSALEM--(BUSINESS WIRE)--Agriculture relies heavily on the use of pesticides in order to maximise crop yield. However, the widespread use of chemical pesticides has resulted in severe environmental pollution, and many pathogens are developing...

July 23, 2012

AUSTIN, Texas and OKLAHOMA CITY--(BUSINESS WIRE)--Biopharmaceutical company Caisson Biotech's $100 million deal with Novo Nordisk, global diabetes care leader, promoted appointment of biotech veteran Glenn Nedwin, PhD, as new Caisson president...

July 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and neurotrauma, today announced that CEO Frank Reynolds is scheduled to...

July 23, 2012

NEW YORK & PETACH TIKVA, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics (OTC:BCLI) announced today that it has completed the planned interim safety review of its Phase I/II ALS (Amyotrophic Lateral Sclerosis) clinical trial, indicating...

July 22, 2012

WASHINGTON--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced final results from the STARTMRK study – the longest double-blind Phase III non-inferiority study evaluating an integrase inhibitor...

July 20, 2012

HENDERSON, Nev. & WESTMINSTER, Colo.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) (Spectrum) and Allos Therapeutics, Inc. (NasdaqGS: ALTH) (Allos) today announced that Spectrum has provided an additional extension of the...

July 20, 2012

NORTH HOLLYWOOD, Calif.--(BUSINESS WIRE)--The IMF says today’s Food and Drug Administration approval of Onyx’s Kyprolis (carfilzomib) offers hope to myeloma patients who have run out of options.

July 20, 2012

TIGARD, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc. (Pink Sheets:BJCT), an innovative developer and manufacturer of needle-free injection therapy systems, today reported unaudited financial results for the year and quarter ended...

July 20, 2012

LAKE ZURICH, Ill. & BAD HOMBURG, Germany--(BUSINESS WIRE)--Fresenius Kabi and Fenwal Inc. announced today a definitive agreement for Fresenius Kabi to acquire Fenwal.

July 20, 2012

WASHINGTON--(BUSINESS WIRE)--Today, Representative Michael Fitzpatrick (R-PA) introduced H.R. 6161, the Fostering Innovation Act, to update SEC filing status classifications for public companies.

July 20, 2012

NORWALK, Conn.--(BUSINESS WIRE)--The Multiple Myeloma Research Foundation (MMRF) today announced that its partner, Onyx Pharmaceuticals, Inc., received U.S. Food and Drug Administration (FDA) approval for Kyprolis™ (carfilzomib).

July 20, 2012

CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Millennium: The Takeda Oncology Company and Takeda announce postive CHMP opinion for conditional approval of brentuximab vedotin in Europe

July 20, 2012

GAINESVILLE, Fla. & UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation and Exactech to Partner in North America on Comprehensive Medical Education Programs to Treat the Continuum of Shoulder and Knee Repair

July 20, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that its collaborator, Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, has received a positive...

July 20, 2012

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda and Millennium: The Takeda Oncology Company announce positive CHMP opinion for conditional approval of brentuximab vedotin in Europe

July 20, 2012

WASHINGTON, D.C.--(BUSINESS WIRE)--New initiative, the Collaboration for HIV/AIDS Immunological Therapy (CHAIT), announced at the HIV Functional Cure Symposium in Washington DC, preceding the international AIDS conference, th

July 20, 2012

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that all resolutions recommended by the...

July 19, 2012

ST. LOUIS--(BUSINESS WIRE)--PKS Online, Certara's hosted software solution to support compliant PK/PD analysis workflows, has been selected as the PK/PD data management solution of choice by a Top 5 Global Pharma company.

July 19, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its second quarter 2012 financial results will be released on Thursday, July 26, at 4:05 p.m. Eastern Time. At 4:15 p.m. Eastern Time, Gilead’s...

July 19, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--BRISK-FL Study with Investigational Compound Brivanib in Hepatocellular Carcinoma Does Not Meet Overall Survival Primary Endpoint

July 19, 2012

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), an innovative developer of adult stem cell technologies and Central Nervous System (CNS) therapeutics, today announced that it completed a...

July 19, 2012

ROCHESTER, Minn.--(BUSINESS WIRE)--Here are highlights from the July issue of Mayo Clinic Health Letter. You may cite this publication as often as you wish. Reprinting is allowed for a fee. Mayo Clinic Health Letter attribution is required....

July 19, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ: EXEL) will release its second quarter 2012 financial results on Thursday, August 2, 2012, after the markets close. The announcement will be followed by a live webcast at 5:00 p...

July 19, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) today announced financial results for the second quarter ended June 30, 2012. Dyax will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and...

July 19, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced results for the second quarter ended June 30, 2012. The Company will host a conference call and webcast today at 5:00 p.m. ET (details below)....

July 19, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) will host a conference call at 8:30 a.m. EDT (1:30 p.m. BST) on Thursday, July 26, 2012, to discuss the company’s financial results for the first quarter of fiscal 2013. Management will review...

July 19, 2012

BEDFORD, Mass--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its second-quarter 2012 financial results after the close of the market on Wednesday, August 1, 2012. The company plans to hold a...